Skip to main content

Butyl 4-[3-[2-(1-piperidyl)ethoxy]indazol-1-yl]benzoate

ADVERTISEMENT
Identification
Molecular formula
C25H29N3O3
CAS number
330786-25-9
IUPAC name
butyl 4-[3-[2-(1-piperidyl)ethoxy]indazol-1-yl]benzoate
State
State

This compound is generally found in a solid state at room temperature. It remains stable under standard conditions of temperature and pressure.

Melting point (Celsius)
165.50
Melting point (Kelvin)
438.65
Boiling point (Celsius)
525.50
Boiling point (Kelvin)
798.65
General information
Molecular weight
437.52g/mol
Molar mass
437.5170g/mol
Density
1.2400g/cm3
Appearence

The compound typically appears as a solid crystalline substance. Its color may range from off-white to pale yellow, depending upon purity and crystal form.

Comment on solubility

Solubility of Butyl 4-[3-[2-(1-piperidyl)ethoxy]indazol-1-yl]benzoate

The solubility of Butyl 4-[3-[2-(1-piperidyl)ethoxy]indazol-1-yl]benzoate is a key factor in understanding its application and effectiveness. This compound is typically characterized by its lipophilic properties, which can impact its dissolution in various solvents.

Factors Influencing Solubility:

  • Polarity of the solvent: Non-polar solvents generally facilitate better solubility for lipophilic compounds like this benzoate derivative.
  • Temperature: Increasing temperature can enhance solubility, though the extent may vary depending on the specific interactions of the compound with the solvent.
  • pH: The ionization state of the compound may change with pH, affecting solubility in aqueous environments.
  • Structural features: The presence of functional groups such as the piperidine moiety may also influence the solubility behavior.

This compound's solubility may be described as limited in aqueous environments, often requiring organic solvents such as chloroform or DMSO for effective dissolution. As a result, solubility can be described in terms of its "hydrophobic" characteristics.

In summary, understanding the solubility of Butyl 4-[3-[2-(1-piperidyl)ethoxy]indazol-1-yl]benzoate involves considering a complex interplay of factors. This complexity emphasizes the need for careful solvent selection in experimental and therapeutic applications.

Interesting facts

Interesting Facts about Butyl 4-[3-[2-(1-piperidyl)ethoxy]indazol-1-yl]benzoate

Butyl 4-[3-[2-(1-piperidyl)ethoxy]indazol-1-yl]benzoate is a fascinating compound that has garnered attention in recent years due to its potential applications in various fields. Here are some noteworthy aspects:

  • Pharmaceutical Potential: This compound is being researched for its potential therapeutic applications, particularly in the fields of neurology and psychiatry.
  • Unique Structure: The compound features a unique indazole ring system, which is a core structure in many bioactive compounds. This structural feature is significant in medicinal chemistry.
  • Interaction with Receptors: The presence of the piperidine moiety suggests the possibility of receptor interactions, specifically in modulating neurotransmitter activity. This could lead to new insights into the treatment of various neurological disorders.
  • Research Applications: Scientists are experimenting with this compound to better understand its biological mechanisms and to identify potential leads for drug development.

In the words of prominent chemists, "The key to unlocking new therapeutic pathways often lies in the nuances of molecular structures." This statement resonates deeply with the ongoing work surrounding Butyl 4-[3-[2-(1-piperidyl)ethoxy]indazol-1-yl]benzoate, where researchers strive to unlock its secrets for medical advancements.

As exploration continues, this compound stands out not just for its complex design, but also for its promise in contributing to crucial medical breakthroughs. The interplay between its molecular design and biological activity is a testament to the intricate world of chemical compounds.

Synonyms
20954-14-7
ITF 632
BRN 0857293
BENZOIC ACID, p-(3-(2-PIPERIDINOETHOXY)-1H-INDAZOL-1-YL)-, BUTYL ESTER
DTXSID90175135
p-(3-(2-Piperidinoethoxy)-1H-indazol-1-yl)benzoic acid butyl ester
DTXCID9097626
RefChem:327826
butyl 4-[3-(2-piperidin-1-ylethoxy)indazol-1-yl]benzoate